We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCO icon
1476
Ducommun
DCO
$2.7B
$1.74M ﹤0.01%
+27,348
New +$1.76M
OLPX
1477
DELISTED
Olaplex Holdings
OLPX
$1.73M ﹤0.01%
1,001,339
+862,419
+621% +$1.72M
EMBC icon
1478
Embecta
EMBC
$214M
$1.73M ﹤0.01%
83,789
-284,246
-77% -$4.66M
HST icon
1479
Host Hotels & Resorts
HST
$17.3B
$1.72M ﹤0.01%
+97,984
New +$1.76M
KNSA icon
1480
Kiniksa Pharmaceuticals
KNSA
$6.07B
$1.72M ﹤0.01%
86,762
-3,809
-4% -$86.9K
ASAN icon
1481
Asana
ASAN
$1.93B
$1.71M ﹤0.01%
+84,529
New +$1.34M
DCOM icon
1482
Dime Commercial Bancshares
DCOM
$1.81B
$1.71M ﹤0.01%
55,631
+46,440
+505% +$1.5M
TPG icon
1483
TPG
TPG
$7.08B
$1.7M ﹤0.01%
+27,072
New +$1.78M
CCRN
1484
DELISTED
Cross Country Healthcare
CCRN
$1.7M ﹤0.01%
93,543
+82,063
+715% +$1.11M
APPS icon
1485
Digital Turbine
APPS
$1.03B
$1.7M ﹤0.01%
+1,004,883
New +$2.24M
SPB icon
1486
Spectrum Brands
SPB
$2.07B
$1.7M ﹤0.01%
20,071
+1,220
+6% +$110K
FIP icon
1487
FTAI Infrastructure
FIP
$468M
$1.69M ﹤0.01%
+233,046
New +$2M
FCNCA icon
1488
First Citizens BancShares
FCNCA
$25B
$1.69M ﹤0.01%
800
+328
+69% +$687K
MXL icon
1489
MaxLinear
MXL
$5.33B
$1.69M ﹤0.01%
85,288
-491,640
-85% -$7.89M
PI icon
1490
Impinj
PI
$4.04B
$1.68M ﹤0.01%
+11,580
New +$2.19M
PAM icon
1491
Pampa Energía
PAM
$4.52B
$1.67M ﹤0.01%
+19,014
New +$1.45M
MLCO icon
1492
Melco Resorts & Entertainment
MLCO
$2.18B
$1.66M ﹤0.01%
287,068
-747,509
-72% -$5.04M
JSPR icon
1493
Jasper Therapeutics
JSPR
$20.1M
$1.66M ﹤0.01%
77,722
+11,397
+17% +$237K
KPTI icon
1494
Karyopharm Therapeutics
KPTI
$159M
$1.63M ﹤0.01%
160,094
+21,279
+15% +$257K
ODC icon
1495
Oil-Dri
ODC
$1.46B
$1.63M ﹤0.01%
37,256
+4,818
+15% +$177K
SOFI icon
1496
SoFi Technologies
SOFI
$21.3B
$1.63M ﹤0.01%
105,947
-8,287,366
-99% -$108M
ARWR icon
1497
Arrowhead Research
ARWR
$11.8B
$1.63M ﹤0.01%
+86,633
New +$1.78M
REYN icon
1498
Reynolds Consumer Products
REYN
$5.42B
$1.62M ﹤0.01%
60,024
-445,815
-88% -$12.6M
KRYS icon
1499
Krystal Biotech
KRYS
$10.5B
$1.62M ﹤0.01%
+10,331
New +$1.83M
PNFP icon
1500
Pinnacle Financial Partners Inc
PNFP
$15.8B
$1.62M ﹤0.01%
+14,137
New +$1.59M

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.